Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides

Antiviral Research

Volumn 55, Issue 2, 2002, Pages 341-355

  Berkhout, Ben ^a   Van Wamel, Jeroen L B ^a   Beljaars, Leonie ^b   Meijer, Dirk K F ^b   Visser, Servaas ^c   Floris, René ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c NIZO FOOD RESEARCH   (Netherlands)

Author keywords

Antiviral activity; Electrostatic virus cell interaction; Milk protein

Indexed keywords

CASEIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; ENVELOPE PROTEIN; LACTOFERRICIN; LACTOFERRIN; MILK PROTEIN; VIRUS PROTEIN;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ARTICLE; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS; HYDROPHOBICITY; IC 50; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS STRAIN;

ANTIVIRAL AGENTS; CELL LINE; GENES, VIRAL; HIV-1; HUMANS; LACTOFERRIN; MILK PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, CCR5; RECEPTORS, CXCR4; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

BOVINAE; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036289423     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(02)00069-4     Document Type: Article

References (67)

1. Oral dextran sulfate (UA001) in the treatment of the acquired immunodefeficiency syndrome (AIDS) and AIDS-related complex
2. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
3. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme
4. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
5. Similarity of chemokines charge and the V3 domain of the HIV-1 Env protein
6. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity
7. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
8. Lactoferrin: A multifunctional immunoregulatory protein?
9. Resistance of the human immunodeficiency virus to the inhibitory action of negatively charged albumins on virus binding to CD4
10. Functionality of β-casein peptides: Importance of amphipathicity for emulsion-stabilizing properties
11. The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface
12. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120
13. Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant
14. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing (SI) phenotype: Analysis by single amino acid substitution
15. Crystal structure of chemically synthesized stromal cell-derived factor 1alpha, a potent ligand for the HIV-1 'fusin' receptor
16. HIV-1 membrane fusion: Targets of opportunity
17. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor
18. Development of resistance of human immunodeficiency virus type 1 to dextran sulphate associated with the emergence of specific mutations in the envelope gp120 glycoprotein
19. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry
20. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
21. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
22. Inhibition of plating of human T cell leukemia virus type I and syncytium-inducing types of human immunodeficiency virus type 1 by polycations
23. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalvirus replication in vitro
24. Inhibition with lactoferrin of in vitro infection with human herpes virus
25. HIV type 1 envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
26. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes
27. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells
28. Use of transglutaminase. Reversible blocking of amino groups in substrate proteins for a high yield of specific products
29. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins
30. HIV-1 co-receptors binding
31. Entry of R5X4 and X4 human immunodeficiency virus type 1 strains is mediated by negatively charged and tyrosine residues in the amino-terminal domain and the second extracellular loop in CXCR4
32. Adaptation of a CCR5-using, primary human immunodeficiency virus type 1 isolate for CD4-independent replication
33. Loss of a single N-linked glycan allows CD4-independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops
34. CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1
35. Mechanism of anti-HIV activity of negatively charged albumins: Biomolecular interaction with HIV-1 envelope protein gp120
36. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus
37. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity
38. CD4-independent use of rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain
39. Microbicides in HIV prevention
40. A human milk factor susceptible to cathepsin D inhibitors enhances human immunodeficiency virus type 1 infectivity and allows virus entry into a mammary epithelial cell line
41. A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection
42. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
43. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
44. Bovine β-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV
45. Breast feeding is a major factor in HIV transmission
46. ELI
47. N-Linked glycosylation 0of the HIV Type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization
48. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection
49. Two ion-exchange chromatographic methods for the isolation of antibacterial peptides from lactoferrin. In situ enzymatic hydrolysis on an ion-exchange membrane
50. s2-casein
51. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding
52. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
53. The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by the envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop
54. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
55. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4
56. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29
57. Conversion of alpha-lactalbumin to a protein inducing apoptosis
58. Negatively-charged albumins: A novel class of polyanionic proteins with a potent anti-HIV activity
59. Charge modification of plasma and milk proteins results in antiviral active compounds
60. Maleylated human serum albumin inhibits HIV-1 infection in vitro
61. Dextran sulfate, a potent anti-HIV agent in vitro having synergism with zidovudine
62. HIV-1 attachment: Another look
63. Peptide substrates for chymosin (rennin). Isolation and substrate behaviour of two tryptic fragments of bovine κ casein
64. Characterization of bovine casein fractions and the kinetics of chymosin-induced macropeptide release from carbohydrate-free and carbohydrate-containing fractions determined by high-performance gel-permeation chromatography
65. The antigenic structure of the HIV gp120 envelope glycoprotein
66. Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1
67. Hepatitis C virus envelope proteins bind lactoferrin